Brief: India's Glaxosmithkline Pharma Posts Dec Qtr Consol Profit
05/02/2021 13:08
Feb 5 (Reuters) - GlaxoSmithKline Pharmaceuticals Ltd
GLAX.NS :
* INDIA'S GLAXOSMITHKLINE PHARMACEUTICALS LTD DEC-QUARTER
CONSOL
PROFIT 1.57 BILLION RUPEES VERSUS LOSS 6.61 BILLION RUPEES YEAR
AGO
* GLAXOSMITHKLINE PHARMACEUTICALS DEC-QUARTER CONSOL REVENUE
FROM
OPERATIONS 8.57 BILLION RUPEES VERSUS 7.79 BILLION RUPEES YEAR
AGO
Source text for Eikon: [ID: https://bit.ly/3jjxU13]
Further company coverage: GLAX.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on GlaxoSmithKline Pharmaceuticals
See all newsGSK India first-quarter profit rises on steady vaccine demand
Brief: Glaxosmithkline Pharma Q1 Consol Profit 2.37 Billion Rupees
Brief: Glaxosmithkline Pharmaceuticals: Receives Demand Notice From National Pharmaceutical Pricing Authority
India's GlaxoSmithKline Pharma gains after Q4 profit rise; PT hike
Brief: Glaxosmithkline Pharmaceuticals March-Quarter Consol Profit 2.78 Billion Rupees